STREPMAG-RO
Roche
Streptavidin Magnetic Particles
suspension
Sinónimos:
magnetic particles, streptavidin
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Código UNSPSC:
12352202
Productos recomendados
Formulario
suspension
envase
pkg of 10 mL (11641786001)
pkg of 2 mL (11641778001)
fabricante / nombre comercial
Roche
Condiciones de envío
wet ice
temp. de almacenamiento
2-8°C
Descripción general
The Streptavidin Magnetic Particles are polydisperse paramagnetic particles that are designed for the fast separation of a variety of biotin-labeled molecules. The particles are supplied in a suspension that contains 10mg particles per ml in 50mM Hepes, 0.1% bovine serum albumin (BSA), 0.01% methyl-isothiazolone, pH 7.4.
Binding capacities per mg streptavidin magnetic particles:
>=1800 pmol free biotin
>150 pmol biotin-labeled oligonucleotide
>10 pmol biotin-labeled dsDNA fragment
Binding capacities per mg streptavidin magnetic particles:
>=1800 pmol free biotin
>150 pmol biotin-labeled oligonucleotide
>10 pmol biotin-labeled dsDNA fragment
Aplicación
The Streptavidin Magnetic Particles are polydisperse paramagnetic particles that are designed for the fast separation of a variety of biotin-labeled molecules. The particles are supplied in a suspension that contains 10 mg particles per ml. The magnetic separation of biotin-labeled molecules has been successfully employed in a wide range of applications.
Otras notas
For life science research only. Not for use in diagnostic procedures.
Palabra de señalización
Warning
Frases de peligro
Consejos de prudencia
Clasificaciones de peligro
Skin Sens. 1
Código de clase de almacenamiento
12 - Non Combustible Liquids
Clase de riesgo para el agua (WGK)
WGK 1
Punto de inflamabilidad (°F)
No data available
Punto de inflamabilidad (°C)
No data available
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Martin Schatte et al.
Bioconjugate chemistry, 27(6), 1484-1492 (2016-05-18)
Enzymes able to ligate biomolecules are emerging tools to generate site-specific bioconjugates. In this study we present a detection and screening method for bioconjugating enzymes which overcomes limitations of analytical methods such as HPLC or MS. These techniques are experimentally
Debolina Ray et al.
Cancer biology & therapy, 13(10), 848-857 (2012-07-13)
Stress treatment generally causes the post-translational modification and accumulation of the p53 protein, although the role of these aspects has not been always understood in relation to this protein's tumor suppressor activity. We analyzed these attributes of p53 in eight
Matthew T Balmer et al.
Cancer biology & therapy, 15(8), 1000-1012 (2014-05-08)
The chemotherapeutic agents doxorubicin (dox) or 5-fluorouracil (5FU) are used to treat cancer cells as they cause irreparable DNA damage, inducing these aberrant cells to undergo cell death. The mediator of this process is presumed to be in part the
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico